A high prevalence of autoimmune thyroid disease (AITD) has been described in Turner's syndrome (TS) 
controls and increased from the first (15%) to the third (30%) decade of life. Clinical AITD was diagnosed in 46% of TS patients with TPO-ab and/or TG-ab. Thyroid-stimulating antibody was detected in the hyperthyroid patient, and TSHB-ab was found in one of eight patients with hypothyroid AT. It was concluded that: TS patients are at higher than average risk of developing AITD not only in adolescence and adult age but also in childhood; hypothyroidism, mainly subclinical, is the most frequent thyroid dysfunction; elevated TPO-ab and/or TG-ab alone do not imply thyroid dysfunction; TS-ab or TSHB-ab are always associated with thyroid dysfunction although most cases of autoimmune hypothyroidism are not due to the latter antibody. Luca Chiovato, Istituto di Endocrinologia, Universit\l=a`\di Pisa, Viale del Tirreno, 64, 56018 Tirrenia, Pisa, Italy A greater prevalence of autoimmune thyroiditis has been described in Turner's syndrome, but the extent of this association is still controversial for both thyroid autoantibody prevalence and clinical impact of thyroid dysfunction. Figures from previous reports in Turner patients range from 3.9% to 87.5% for thyroid auto¬ antibody prevalence and from 4.3% to 40% for labora¬ tory or clinical evidence of thyroid dysfunction (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) . An association between autoimmune thyroiditis and a particular karyotype (the X-isochromosome) responsi¬ ble for Turner's syndrome was also hypothesized (6) (7) (12) (13) but, with one exception (10) , studies on this aspect concerned only a small number of patients with this karyotype.
An aspect of the association between thyroid auto¬ immunity and Turner's syndrome is the low prevalence of Graves' hyperthyroidism (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) . In view of its etiopathogenetic relationship with autoimmune thyroiditis (14, 15) , Graves' disease should be expected to be more frequent in Turner's syndrome, but this combination has been described only in anecdotal reports (3, (16) (17) (18) (19) . In this regard, TSH-receptor antibodies with thyroidstimulating or TSH-blocking activity have not been investigated systematically in Turner's syndrome. All previous studies in this syndrome were concerned with the prevalence of thyroid peroxidase (formerly defined as "microsomal") and thyroglobulin antibodies. These antibodies, while being good markers of thyroid autoimmunity, probably do not exert a direct pathogenetic effect by themselves (14, 15, 20) . On the other hand, antibodies to the TSH-receptor with thyroidstimulating or TSH-blocking activity are directly involved in the pathogenesis of thyroid dysfunction in autoimmune thyroid diseases (21, 22 (25, 26) . Before the assay, the culture medium was aspirated and cells were washed with Hank's balanced salt solution.
The IgGs were dialyzed in hypotonie buffer (27) (3, (16) (17) (18) (19) . The reason for this low incidence of Graves' disease, despite its genetic and pathogenetic relation¬ ship with autoimmune thyroiditis (14, 15) , is poorly understood, but probably reflects the higher frequency of asymptomatic autoimmune thyroiditis with respect to Graves' disease in the general population (28) . With specific regard to thyroid autoimmune diseases in Turner patients, it has been hypothesized that the Xisochromosome might play a role, because this chrom¬ osomal abnormality has been reported more frequently in patients with associated Hashimoto's thyroiditis than in those with associated Graves' disease (1, 6, 7, 10, 12, 13, 16 (21, 22) . Using the FRTL-5 cell culture system, TS-ab can be detected in more than 90% of untreated patients with Graves' disease (21, 22) . In the present series of patients with Turner's syndrome, TS-ab was found in the one with Graves' hyperthyroid¬ ism. Thyrotropin-receptor antibodies with blocking activity (TSHB-ab) were found in one out of eight Turner patients with hypothyroidism. TSHB-ab have been described in patients with autoimmune hypo¬ thyroidism (25) , in particular in those with auto¬ immune atrophie thyroiditis (idiopathic myxedema) (25, 31) . In different series of patients with AAT, the prevalence of TSHB-ab ranges from 14% to nearly 80% (32) , but in our experience the prevalence of TSHB-ab in AAT is around 30% (33) . Therefore, TSHB-ab are present in only a minority of patients with autoimmune hypothyroidism, while in most cases the accompanying lymphocytic destruction of the thyroid plays a major pathogenetic role (14, 15 ). This appears to be the case also in thyroid autoimmune diseases associated with Turner's syndrome, because only one out of eight hypothyroid patients was found positive for TSHB-ab.
With specific regard to the two Turner patients with autoimmune thyroiditis and overt hypothyroidism but negative results for all thyroid autoantibodies, it must be recalled that L-thyroxine therapy may reduce serum levels of TPO-ab, TG-ab (34) and TSHB-ab (35) . On the other hand, negative antibody titers in Turner patients with thyroid abnormalities have been reported in other studies (5) (6) (7) . The possibility of negative antibody tests in chronic juvenile autoimmune thyroiditis has also been described in the general population (7, 36) .
Other endocrine autoimmune disorders, such as idiopathic Addison's disease, have also been described in association with Turner's syndrome (37) (38) (39) 
